Noninvasive measurement of cerebral blood flow and glucose metabolic rate in the rat with high-resolution animal positron emission tomography (PET): a novel in vivo approach for assessing drug action in the brains of small animals.
Noninvasive measurement of cerebral blood flow and glucose metabolic rate in the rat with high-resolution animal positron emission tomography (PET): a novel in vivo approach for assessing drug action in the brains of small animals.
复制标题
利用高分辨率动物正电子发射断层扫描 (PET) 无创测量大鼠脑血流量和葡萄糖代谢率:一种评估小动物大脑药物作用的新型体内方法。
DOI:
10.1248/bpb.18.753
复制
发表时间:
1995
影响因子:
2
通讯作者:
H. Okada
中科院分区:
文献类型:
--
作者:
Y. Magata;H. Saji;S. Choi;K. Tajima;T. Takagaki;S. Sasayama;Y. Yonekura;H. Kitano;M. Watanabe;H. Okada
The cerebral metabolic rate of glucose (CMRglc) and cerebral blood flow (CBF) in rats were estimated noninvasively with a high-resolution animal positron emission tomography (PET) system that we recently developed. Qualifications of CMRglc and CBF were attempted with radiotracers, 18F-2-fluoro-2-deoxyglucose and 15O-water, respectively. From the data obtained with PET, the CMRglc and CBF values under pretreatment conditions were respectively calculated as 51 +/- 14 mumol/min/100 g and 61 +/- 7 ml/min/100 g under pentobarbital-anesthesia. These values were in close agreement with published data obtained with the autoradiographic technique. Moreover, an increase of 69% (mean) in CBF was detected after i.v. acetazolamide administration. The results indicate that this high-resolution animal PET scanner holds great potential for the assessment of drug-related metabolic and circulatory effects in intact and experimental animals.